Bioregenx (BRGX) Interest & Investment Income (2022 - 2023)

Bioregenx (BRGX) posted quarterly Interest & Investment Income of -$100.0 for Q4 2023, up 99.8% quarter-over-quarter from -$50800.0 in Q3 2023.

Bioregenx (BRGX) Interest & Investment Income (2022 - 2023) Analysis & Trends

Bioregenx's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$100.0 for Q4 2023.

In Q4 2023, Interest & Investment Income changed N/A year-over-year to -$100.0; the TTM figure through Dec 2023 stood at -$20900.0 (up 46.41% YoY), while the FY2023 annual figure was -$20900.0, up 46.41% from the prior year.
Interest & Investment Income for Q4 2023 stood at -$100.0, up from -$50800.0 in the prior quarter.
The five-year high for Interest & Investment Income was $21000.0 in Q1 2023, with the low at -$79400.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-27.45 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	4.80 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-16,000.00
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	2.31 Mn
10	Bioregenx	9.72 Mn	9.67 Mn	348,288.00	-

Download Data